Apoorva Ramaswamy | Medicine | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Apoorva Ramaswamy | Medicine | Best Researcher Award

 👤Assist. Prof. Dr. Apoorva Ramaswamy, The Ohio State University Wexner Medical Center, United States

Dr. Apoorva Tewari Ramaswamy is an Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Ohio State University Wexner Medical Center. With a distinguished academic and clinical career, she has contributed significantly to the fields of laryngology and dysphagia. She earned her medical degree from Yale School of Medicine, where she was honored with the prestigious Samuel Jordan Graham Scholarship. Dr. Ramaswamy is dedicated to advancing patient care, research, and education. She has an active role in the Dysphagia Research Society and serves on multiple committees, focusing on diversity, equity, and inclusion (DEI). Her career is marked by academic excellence, innovative research, and an enduring commitment to improving patient outcomes.

Professional Profile

Scopus

Orcid

🌟  Summary of Suitability for the “Research for Best Researcher Award”

Apoorva Tewari Ramaswamy, MD, is exceptionally well-suited for the “Research for Best Researcher Award” due to her extensive educational background, significant research contributions, leadership in her field, and dedication to advancing medical science. She completed her MD from Yale School of Medicine, where she was awarded the Samuel Jordan Graham Scholarship for demonstrating exceptional academic promise in surgery. Additionally, her recognition as Yale College’s Commencement Flag Bearer highlights her extraordinary contributions not only in academia but also within her community.

Dr. Ramaswamy’s research in the fields of laryngology, dysphagia, and esophagology has been widely recognized. She has published influential work, including studies that explore the role of local IgE in eosinophilic esophagitis, which earned her the AAOA Research Prize. Her research contributions continue through her leadership role in various committees and advisory boards, such as the Dysphagia Research Society and the American Broncho-Esophagological Association.

🎓 Education

Dr. Ramaswamy completed her Doctor of Medicine (MD) at Yale School of Medicine (2011–2015), where she was awarded the Samuel Jordan Graham Scholarship for her final year. She also holds a Bachelor of Science in Molecular, Developmental, and Cellular Biology from Yale College (2007-2011), where she was recognized as the Commencement Flag Bearer for her extraordinary contributions. Early in her education, Dr. Ramaswamy earned the “Triple C” award from the Attorney General of New York State, showcasing her excellence in academics and extracurricular leadership during high school. She also demonstrated athletic prowess, earning Volleyball All League honors and the Sirena Wu Dunn Award. Throughout her education, Dr. Ramaswamy’s academic achievements have consistently set her apart as a leader and innovator.

💼 Professional Experience

Dr. Ramaswamy is currently an Assistant Professor at Ohio State University Wexner Medical Center in the Department of Otolaryngology-Head and Neck Surgery. She completed a fellowship in Laryngology and Bronchoesophagology at UC Davis (2020-2021) and residency in Otolaryngology at New York Presbyterian Hospital (2015-2020), where she received several prestigious awards, including the AAOA Research Prize and the Distinguished House Staff Award. Dr. Ramaswamy also has experience working internationally, with a 2009 internship at PEPFAR-Nigeria and research at Yale on vascular surgery. She has served as a faculty member, mentor, and leader in various medical and academic committees, including the Dysphagia Research Society and the American Broncho-Esophagolical Association, advancing research and educational initiatives in her field.

🏅 Awards and Recognition

Dr. Ramaswamy’s career has been marked by several notable accolades. She was honored with the prestigious James Physician Patient Champion Award in 2024. Throughout her residency, she received multiple awards, such as the AAOA Research Prize and In-Service Prize for her academic excellence. As a faculty member, she has received recognition from various professional societies, including the American Head & Neck Society and the Dysphagia Research Society, where she holds leadership positions. Her achievements in academic surgery were further acknowledged with the Distinguished House Staff Award from Weill Cornell Medical Center in 2019, signifying her contributions to patient care, education, and research.

🌍 Research Skills On Medicine

Dr. Ramaswamy’s research is centered around the treatment of dysphagia, laryngology, and the impacts of esophagology on patients with head and neck cancer. Her research contributions have been presented at prestigious international conferences, with a focus on the intersection of voice and swallowing disorders. Dr. Ramaswamy has also conducted studies on local IgE in eosinophilic esophagitis, which won second place at the 2018 AAOA meeting. As a leader in the Dysphagia Research Society and various academic committees, she has promoted diversity and inclusion within the research community. Her work continues to advance understanding of swallowing disorders and provides practical solutions for patient care.

📖 Publication Top Notes

  1. The efficacy of two commercially available devices for airway foreign body relief: A cadaver study

    • Authors: Ramaswamy, A.; Done, A.; Solis, R.; Srikanth, M.; Olinde, L.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1057

  2. Tongue base augmentation to improve swallow function in a cadaveric model

    • Authors: Ramaswamy, A.T.; Cates, D.; Evangelista, L.; Srikanth, M.; Belafsky, P.
    • Citation: Laryngoscope Investigative Otolaryngology, 2023
    • DOI: 10.1002/lio2.1041

  3. The upper esophageal sphincter: anatomy and physiology

    • Authors: Ramaswamy, A.T.; Martell, P.; Azevedo, R.; Belafsky, P.
    • Citation: Annals of Esophagus, 2022
    • DOI: 10.21037/aoe-21-34

  4. Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry.

  5. Office-Based Procedure Training in Laryngology Fellowship Programs.

    • Authors: Enver N.; Ramaswamy A.; Sulica L.; Pitman MJ
    • Citation: The Laryngoscope, 2020-10
    • DOI: 10.1002/lary.29170
    • PMID: 33043999

  6. How I Do It: A Novel Technique for Endoscopic Placement of Stent in Management of Anterior Glottic Webs.

    • Authors: Enver N.; Ramaswamy A.; Pitman MJ
    • Citation: The Laryngoscope, 2020-09
    • DOI: 10.1002/lary.28965
    • PMID: 32902885

  7. Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City.

    • Authors: Long SM; Chern A; Feit NZ; Chung S; Ramaswamy AT; Li C; Cooley V; Hill S; Rajwani K; Villena-Vargas J, et al.
    • Citation: Annals of Surgery, 2020-09
    • DOI: 10.1097/sla.0000000000004428
    • PMID: 32889885

  8. Common Otologic Surgical Procedures: Clinical Decision-Making Pearls and the Role of Imaging

    • Authors: Peng, T.; Ramaswamy, A.T.; Kim, A.H.
    • Citation: Neuroimaging Clinics of North America, 2019
    • DOI: 10.1016/j.nic.2018.09.008

  9. Management of Vestibular Schwannomas for the Radiologist

  10. Carcinoma presenting as idiopathic anterior glottic webs: A case series

    • Authors: Ramaswamy, A.T.; Tian, L.; Bock, J.M.; Klein, A.M.; Pitman, M.J.
    • Citation: The Laryngoscope, 2019-09
    • DOI: 10.1002/lary.27711

Siying Li | Cardiovascular diseases | Best Researcher Award

Posted on by sciencefather

Dr. Siying Li | Cardiovascular diseases | Best Researcher Award

Dr. Siying Li, Central Hospital affiliated to Shandong First Medical University, China

Dr. Siying Li is an Associate Research Fellow at the Metabolism and Disease Research Center, Central Hospital affiliated with Shandong First Medical University, China. She holds a Ph.D., M.M., and M.B. from Shandong University and has conducted postdoctoral research in cardiometabolic diseases. Her work focuses on hydrogen sulfide regulation in mitochondria, autophagy in heart failure, and ferroptosis in metabolic disorders. With experience as a Visiting Scholar at the University of South Carolina, U.S., she has contributed significantly to medical research. Her findings have been widely recognized, making her a leading researcher in metabolism and cardiovascular health.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Siying Li’s academic journey is marked by excellence and dedication to medical research. She earned her Ph.D. (2010-2015), M.M. (2009-2010), and M.B. (2003-2009) from Shandong University, China, a prestigious institution known for its contributions to medical science. Her strong academic foundation laid the groundwork for her specialization in metabolism and disease research, with a keen focus on cardiometabolic disorders.

💼 PROFESSIONAL ENDEAVORS:

Dr. Li’s career progression reflects her commitment to medical research and academia. She is currently an Associate Research Fellow at the Metabolism and Disease Research Center, Central Hospital affiliated with Shandong First Medical University (2023-Present). Previously, she held key research positions, including:
🔹 Associate Research Fellow at the Shandong Institute of Endocrine and Metabolic Disease (2021-2023)
🔹 Assistant Research Fellow at the Department of Pathophysiology, School of Basic Medicine, Shandong University (2017-2020)
🔹 Postdoctoral Researcher at Shandong University (2015-2017)
🔹 Visiting Scholar at the University of South Carolina, U.S. (2011-2013)

Her extensive experience in both national and international institutions has provided her with a global perspective on medical research, fostering interdisciplinary collaborations.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Li’s research is centered on cardiometabolic diseases, an area of growing significance in modern medicine. Her key research contributions include:
✅ Hydrogen Sulfide & Mitochondria in Heart Failure – Investigating its regulatory role in cellular metabolism and autophagy.
✅ Iron Metabolism & Ferroptosis in Cardiometabolic Diseases – Exploring its potential in disease progression and therapeutic interventions.

Her work has advanced the understanding of molecular mechanisms in cardiovascular health, paving the way for potential breakthroughs in medical treatments.

🌍 IMPACT AND INFLUENCE:

Dr. Li’s research has made a significant impact on the global scientific community, particularly in the fields of metabolism, endocrinology, and cardiovascular health. Her studies on ferroptosis and hydrogen sulfide regulation have influenced new treatment approaches for heart failure and metabolic disorders. Her collaborations with leading research institutions and hospitals have further amplified the clinical relevance of her findings.

📚 ACADEMIC CITATIONS AND RECOGNITION:

Dr. Li’s work has been widely recognized in peer-reviewed journals and international conferences. Her research has garnered numerous citations, reflecting its significance and contribution to the medical field. She has also actively participated in academic symposiums and medical panels, sharing her insights with researchers worldwide.

🚀 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Li’s ongoing research promises to make groundbreaking contributions to medicine. Her expertise in molecular metabolism and cardiovascular pathophysiology positions her as a key figure in the future of personalized medicine and targeted therapies. Her dedication to advancing scientific knowledge and mentoring young researchers ensures a lasting impact on the field of medical science.

🏅 CONCLUSION:

Dr. Siying Li is a distinguished researcher whose contributions to cardiometabolic diseases have significantly advanced medical science. Her expertise in hydrogen sulfide regulation, mitochondrial function, and ferroptosis has provided valuable insights into heart failure and metabolic disorders. With a strong academic background, extensive research experience, and international collaborations, she has established herself as a leading scientist in her field. Her work not only enhances fundamental understanding but also paves the way for innovative therapeutic approaches.

TOP NOTABLE PUBLICATIONS

The potential role of hydrogen sulfide in regulating macrophage phenotypic changes via PINK1/parkin-mediated mitophagy in sepsis-related cardiorenal syndrome

Authors: Chen, Y., Cao, W., Li, B., … Yang, G., Li, S.

Journal: Immunopharmacology and Immunotoxicology

Year: 2024

Cyclophilin D as a potential therapeutic target of liver ischemia/reperfusion injury by mediating crosstalk between apoptosis and autophagy

Authors: Yang, M., Wang, Z., Xie, J., … Li, S., Song, Y.

Journal: Chronic Diseases and Translational Medicine

Year: 2023

 Urine proteomics for profiling of mouse toxoplasmosis using liquid chromatography tandem mass spectrometry analysis

Authors: Cui, L.-L., Zhou, C.-X., Han, B., … Xie, S.-C., Zhou, D.-H.

Journal: Parasites and Vectors

Year: 2021

S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways

Authors: Mo, M., Li, S., Dong, Z., … Li, A., Zhao, Z.

Journal: International Immunopharmacology

Year: 2020

The key role of macrophage depolarization in the treatment of COPD with ergosterol both in vitro and in vivo

Authors: Sun, X., Liu, Y., Feng, X., … Li, S., Zhao, Z.

Journal: International Immunopharmacology

Year: 2020

S-allylmercaptocysteine targets NRF2 in osteoarthritis treatment through NOX4/NF-ΚB pathway

Authors: Yang, G., Sun, S., Wang, J., … Yuan, L., Li, S.

Journal: Drug Design, Development and Therapy

Year: 2020

 A nucleoside/nucleobase-rich extract from Cordyceps sinensis inhibits the epithelial-mesenchymal transition and protects against renal fibrosis in diabetic nephropathy

Authors: Dong, Z., Sun, Y., Wei, G., Li, S., Zhao, Z.

Journal: Molecules

Year: 2019

Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis in vitro and in vivo

Authors: Sun, X., Feng, X., Zheng, D., … Li, S., Zhao, Z.

Journal: Clinical Science

Year: 2019

 Yifei tongluo, a Chinese herbal formula, suppresses tumor growth and metastasis and exerts immunomodulatory effects in Lewis lung carcinoma mice

Authors: Qi, Q., Hou, Y., Li, A., … Li, S., Zhao, Z.

Journal: Molecules

Year: 2019

Ergosterol ameliorates diabetic nephropathy by attenuating mesangial cell proliferation and extracellular matrix deposition via the TGF-β1/Smad2 signaling pathway

Authors: Dong, Z., Sun, Y., Wei, G., Li, S., Zhao, Z.

Journal: Nutrients

Year: 2019

Do Young Kim | Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Do Young Kim | Medicine | Best Researcher Award

Prof. Do Young Kim, Yonsei University College of Medicine South Korea

Do Young Kim is a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Having been part of the faculty since 2007, Dr. Kim is widely recognized for his contributions to hepatology, particularly in hepatocellular carcinoma (HCC). He earned his medical degree from Yonsei University in 1996 and completed his training at Severance Hospital. Dr. Kim’s research experience includes a position as a research associate at Fred Hutchinson Cancer Research Center from 2011 to 2012, where he focused on proteomics and microRNA in HCC.

Professional Profile 

Scopus 

Orcid

Google Scholar

Summary of Suitability for the “Research for Best Researcher Award”

Professor Do Young Kim, a prominent figure in hepatology and internal medicine, has made significant contributions to the field of hepatocellular carcinoma (HCC) and hepatitis C research. As a professor at Yonsei University College of Medicine and a hepatologist at Severance Hospital, he has established himself as a leading expert in his field since 2007. His academic background, including his degree from Yonsei University and specialized training at Severance Hospital, laid a solid foundation for his remarkable career.

His research focus on proteomics and microRNA in HCC, particularly during his tenure at the Fred Hutchinson Cancer Research Center, has led to innovative insights into the mechanisms underlying liver cancer and hepatitis C. This focus has translated into a series of impactful publications, where he has served as the corresponding author in studies that explore new treatment paradigms and diagnostic advancements for HCC. His work on the efficacy and safety of various treatments, including sorafenib and lenvatinib, has become essential reading for clinicians and researchers alike.

🎓 Education 

Dr. Do Young Kim obtained his medical degree from Yonsei University in Seoul, Korea, in 1996. After completing his studies, he underwent medical training at Severance Hospital, where he continued his professional development until 2001. In 2011, Dr. Kim broadened his academic horizons by becoming a research associate at Fred Hutchinson Cancer Research Center, where he focused on proteomics and microRNA in hepatocellular carcinoma (HCC). This international research experience allowed him to deepen his expertise in the molecular aspects of liver cancer. Dr. Kim’s ongoing contributions to medical education and his research have been deeply influenced by his foundational education and global training experiences.

💼 Professional Experience 

Dr. Do Young Kim is currently serving as a Professor of Internal Medicine at Yonsei University College of Medicine and a hepatologist at Severance Hospital in Seoul, Korea. Since joining Severance Hospital in 2007, he has become an integral part of the team, specializing in hepatology and liver diseases. His research has advanced understanding in areas such as hepatocellular carcinoma (HCC) and hepatitis C. In 2011-2012, Dr. Kim expanded his professional expertise by working as a research associate at the Fred Hutchinson Cancer Research Center in Seattle, USA. There, he conducted cutting-edge research in proteomics and microRNA in relation to HCC, which added a new dimension to his medical and scientific career. His ongoing clinical and research contributions have made him a leader in the field of hepatology.

🏅 Awards and Recognition

Dr. Do Young Kim has received significant recognition in the field of hepatology, with several prestigious awards throughout his career. His research on hepatocellular carcinoma (HCC) and hepatitis C has earned him acknowledgment both nationally and internationally. He is particularly recognized for his contributions to clinical practices surrounding HCC and his extensive publication record in highly respected medical journals. His role as a corresponding author in key studies, such as those published in Hepatology and J Gastroenterol Hepatol, highlights his leadership in advancing knowledge about liver disease. Dr. Kim’s research and clinical expertise have earned him the trust and respect of colleagues in the medical community, solidifying his position as a leading expert in the field of internal medicine and hepatology.

🌍 Research Skills On Medicine

Dr. Do Young Kim’s research skills are highly regarded, particularly in the fields of hepatocellular carcinoma (HCC) and hepatitis C. He specializes in proteomics and microRNA, utilizing these molecular techniques to gain deeper insights into the pathophysiology of liver diseases. His time at the Fred Hutchinson Cancer Research Center honed his skills in advanced research methodologies, which he continues to apply in his work at Severance Hospital and Yonsei University College of Medicine. Dr. Kim’s research is both experimental and clinical, bridging the gap between laboratory findings and real-world medical applications. He is skilled in conducting large-scale studies, analyzing complex data, and collaborating with multidisciplinary teams to advance scientific understanding. His research has led to significant clinical improvements in the management of liver diseases, particularly in HCC treatment and early detection.

📖 Publication Top Notes

  • Letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
    • Authors: Chon, Y.E., Kim, D.Y., Chon, H.J., Kim, D.Y.
    • Citation: Clinical and Molecular Hepatology, 2025, 31(1), pp. e98–e100
  • The Possible Impact of Zinc-Enriched Multivitamins on Treatment-Naïve Recurrent Aphthous Stomatitis Patients
    • Authors: Seo, H.R., Chung, K.B., Kim, D.-Y.
    • Citation: Journal of Clinical Medicine, 2025, 14(1), 260
  • Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
    • Authors: Kim, J.E., Lee, S., Kang, H., Lee, Y.W., Kim, M.-B.
    • Citation: Annals of Dermatology, 2024, 36(6), pp. 376–383
  • Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
    • Authors: Kim, K.-P., Kim, K.M., Ryoo, B.-Y., Kim, J.-A., Kim, K.-H.
    • Citation: Liver Cancer, 2024, 13(6), pp. 610–628
  • Detection of NUDT15 R139C Variants and Azathioprine Utilization in Patients with Dermatologic Conditions
    • Authors: Chung, K.B., Sung, H., Kim, D.-Y.
    • Citation: International Journal of Dermatology, 2024, 63(3), pp. e75–e77
  • Quantitative Analysis of Hair Luster in a Novel Ultraviolet-Irradiated Mouse Model
    • Authors: Chung, K.B., Lee, Y.I., Kim, Y.J., Kim, D.-Y., Lee, J.H.
    • Citation: International Journal of Molecular Sciences, 2024, 25(3), 1885
    • Citations: 1
  • Heterogeneity in Keloid Scars: Influence of Mechanical Stretching on Keloids Arising from Different Anatomical Sites
    • Authors: Lee, Y.I., Yang, Y., Ham, S., Kim, D.-Y., Lee, J.H.
    • Citation: Journal of Investigative Dermatology, 2024
  • The Efficacy of Treatment for Hepatocellular Carcinoma in Elderly Patients
    • Authors: Lee, H.A., Lee, S., Lee, H.L., Rhim, H., Kim, D.Y.
    • Citation: Journal of Liver Cancer, 2023, 23(2), pp. 362–376
    • Citations: 2
  • Predictive Biomarkers of Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Treatment
    • Authors: Chon, Y.E., Cheon, J., Kim, H., Chon, H.J., Kim, B.K.
    • Citation: Cancer Medicine, 2023, 12(3), pp. 2731–2738
    • Citations: 26
  • Activated TAZ Induces Liver Cancer in Collaboration with EGFR/HER2 Signaling Pathways
    • Authors: Moon, H., Park, H., Chae, M.J., Kim, D.Y., Ro, S.W.
    • Citation: BMC Cancer, 2022, 22(1), 423
    • Citations: 11

Anna Cecilia Trolesi Reis Borges Costa | Epidemiology | Best Researcher Award

Posted on by sciencefather

Dr. Anna Cecilia Trolesi Reis Borges Costa | Epidemiology | Best Researcher Award

👤 Dr. Anna Cecilia Trolesi Reis Borges Costa, Federal University of Lavras, Brazil

Anna Cecília Trolesi Reis Borges Costa, born on April 5, 1991, is a Brazilian veterinarian with a strong focus on epidemiology. She earned her Ph.D. in Veterinary Sciences from Universidade Federal de Lavras (UFLA) in 2024, with research exploring bovine brucellosis surveillance and control in Minas Gerais. Anna’s career spans a range of professional experiences, including working as a small animal clinician, a volunteer teacher in epidemiology, and a visiting professor at Brazilian universities. She is recognized for her extensive research in veterinary epidemiology and public health, particularly in zoonotic diseases like leptospirosis and brucellosis. Her contributions to the field are supported by multiple grants, including the prestigious CNPq Postdoctoral Abroad Scholarship. Currently, she continues her work internationally, with a focus on advancing veterinary science and public health.

Professional Profile

Orcid

🌟 Assessment of Suitability for the “Research for Best Researcher Award”

Dr. Anna Cecília Trolesi Reis Borges Costa’s exceptional academic and professional journey demonstrates her strong eligibility for the “Research for Best Researcher Award.” Her contributions to veterinary sciences, with a focus on epidemiology, public health, and infectious disease control, align with the criteria of groundbreaking research and societal impact.

Dr. Costa has a robust academic background, completing her PhD in Veterinary Sciences at the Universidade Federal de Lavras in 2024, with international collaborations at the University of Illinois and the University of Prince Edward Island. Her thesis on risk-based bovine brucellosis surveillance and control highlights her innovative approach to addressing critical challenges in veterinary public health. Complementing this, her Master’s dissertation focused on a “One Health” approach to leptospirosis, showcasing her commitment to interdisciplinary research that integrates animal, human, and environmental health.

🎓 Education 

Anna Cecília Trolesi Reis Borges Costa’s educational journey includes a series of distinguished academic accomplishments. She holds a Ph.D. in Veterinary Sciences from Universidade Federal de Lavras (2024), where her thesis focused on “Risk-based bovine brucellosis surveillance and control.” This was pursued during a collaborative period at the University of Illinois. Anna also completed her Master’s in Veterinary Sciences at UFLA in 2020, researching “Epidemiology of leptospirosis in humans and unowned dogs,” which emphasized the One Health approach. She received several prestigious grants throughout her academic career, including from CAPES and the Canadian Government for further specialization in epidemiology at the University of Prince Edward Island in 2022. Anna completed her undergraduate degree in Veterinary Medicine at UFLA in 2014. Her academic background has laid a strong foundation for her work in epidemiology and public health.

💼   Professional Experience

Anna Cecília Trolesi Reis Borges Costa’s professional journey includes several roles in the field of veterinary science, with a particular focus on epidemiology. From 2019 to 2024, she served as a volunteer teacher in epidemiology and public health at UFLA. In 2021, she expanded her teaching experience as a visiting professor at both Universidade Federal de Alfenas and Universidade Santo Amaro in Brazil. Anna also worked as a government employee in Três Corações, Brazil, offering specialized technical services as a small animal clinician and at a local shelter. Her clinical expertise was further honed through her roles at Recanto Animal and Bicho Chic Veterinary Clinic, where she worked with small animals. Additionally, Anna has gained practical experience in large animal reproduction during her internship at UFLA’s veterinary hospital. Her multidisciplinary experience makes her an invaluable contributor to both education and clinical veterinary practice.

🏅Awards and Recognition 

Anna Cecília Trolesi Reis Borges Costa has been recognized for her outstanding academic and professional contributions to veterinary science and epidemiology. Her most notable accolade is the CNPq Postdoctoral Abroad Scholarship, which enabled her to pursue further studies in veterinary science. Additionally, she has received multiple grants, including funding from CAPES (Brazil) and the Canadian Government for her specialization in epidemiology. Anna’s research in veterinary epidemiology, particularly in zoonotic diseases, has earned her several citations in international journals. Her work in the prevention and control of bovine brucellosis and leptospirosis in public shelters has been pivotal to advancing veterinary public health. Anna’s efforts in epidemiology education, research, and fieldwork have made her a respected figure in the veterinary community, and her expertise continues to be recognized by academic institutions and scientific bodies worldwide.

🌍 Research Skills On Epidemiology

Anna Cecília Trolesi Reis Borges Costa’s research skills are rooted in her extensive training in veterinary science, epidemiology, and public health. She excels in data analysis and epidemiologic modeling, crucial for assessing and controlling zoonotic diseases. Her research expertise spans a wide range of subjects, from molecular biology and microbiology to collective health. Anna has developed robust research methodologies, including spatiotemporal analysis and network analysis, to assess disease outbreaks and health risks. Her ability to conduct comprehensive risk assessments and surveillance studies is evident in her work on bovine brucellosis and leptospirosis in Brazil. Furthermore, Anna is highly skilled in integrating One Health approaches into her research, which considers the interconnectedness of human, animal, and environmental health. Her research has led to significant publications in peer-reviewed journals, demonstrating her aptitude in advancing veterinary epidemiology and contributing valuable knowledge to the scientific community.

📖 Publication Top Notes

  • Clinical-epidemiological profile of the canine population in a shelter, Minas Gerais, Brazil, 2019-2020
    • Authors: Raisa Abreu Bragança Colocho, Anna Cecília Trolesi Reis Borges Costa, Blenda Araujo Martins Ferreira, Amanda Carvalho Rosado Ferreira, Dircéia Aparecida da Costa Custódio, Carine Rodrigues Pereira, Erika Aparecida Oliveira, Isaac David Pineda Sirias, Sérgio Novais de Melo, Ana Beatriz Barion Souza, et al.
    • Citation: Colocho, R.A.B., Costa, A.C.T.R.B., Ferreira, B.A.M., Ferreira, A.C.R., Custódio, D.A.C., Pereira, C.R., Oliveira, E.A., Sirias, I.D.P., Melo, S.N., Souza, A.B.B. (2025). Clinical-epidemiological profile of the canine population in a shelter, Minas Gerais, Brazil, 2019-2020. Journal of Applied Animal Welfare Science.
  • Resistance Training Improves the Immune Response, Mainly Associated with CD8+ T Lymphocytes and B Lymphocytes, in Mice
    • Authors: Fernanda Cristina Pedro, Marina Martins de Oliveira, Rafaella Silva Andrade, Anna Cecília Trolesi Reis Borges Costa, Carine Rodrigues Pereira, Pedro Felipe Rodrigues e Oliveira, Soraia Macari, Cândido Celso Coimbra, Elaine Maria Seles Dorneles, Luciano José Pereira
    • Citation: Pedro, F.C., de Oliveira, M.M., Andrade, R.S., Costa, A.C.T.R.B., Pereira, C.R., Rodrigues e Oliveira, P.F., Macari, S., Coimbra, C.C., Dorneles, E.M.S., Pereira, L.J. (2024). Resistance training improves the immune response, mainly associated with CD8+ T lymphocytes and B lymphocytes, in mice. Brazilian Archives of Biology and Technology.
  • Network vulnerability of cattle movement in Minas Gerais, Brazil, from 2013 to 2022
    • Authors: Anna Cecília Trolesi Reis Borges Costa, Lara Savini, Luciana Faria de Oliveira, Andrey Pereira Lage, Elaine Maria Seles Dorneles, Luca Candeloro
    • Citation: Costa, A.C.T.R.B., Savini, L., de Oliveira, L.F., Lage, A.P., Dorneles, E.M.S., Candeloro, L. (2024). Network vulnerability of cattle movement in Minas Gerais, Brazil, from 2013 to 2022.

FANCY GAETE | Medicine | Women Researcher Award

Posted on by sciencefather

Dr. FANCY GAETE | Medicine | Women Researcher Award

👤 Dr. FANCY GAETE, HOSPITAL SANTIAGO ORIENTE DR. LUIS TISNÉ BROUSSE, Chile

Dr. Fancy Gaete Verdejo is a renowned anatomopathologist with 26 years of experience in Chile’s public healthcare system. As a pioneer in breast cancer diagnostics, she established the national reference center for the in situ hybridization technique for HER2 testing, which has been operational since 2011. In 2022, she transitioned from the manual FISH HER2 technique to the automated DISH HER2 method, integrating digital pathology and AI algorithms. This innovation led to a 13.02% reduction in costs, an 83.86% improvement in response time, and an 11.29% increase in productivity. Dr. Gaete is actively involved in the advancement of pathology practices and plays a leadership role as the President of the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology.

Professional Profile

Scopus

🌟  Assessment of Suitability for the Research for Women Researcher Award

Summary of Suitability
Dr. Fancy Gaete Verdejo exemplifies an exceptional commitment to advancing research and innovation in pathology, specifically breast cancer diagnostics, within the Chilean public health system. Her pioneering efforts to centralize the HER2 in situ hybridization technique have significantly impacted breast cancer pathology in Chile. By introducing the automated DISH HER2 technique integrated with digital pathology and artificial intelligence (AI) algorithms, she has revolutionized diagnostic efficiency, reducing costs by 13.02%, cutting response times by 83.86%, and improving productivity by 11.29%.

Dr. Verdejo’s leadership in developing a national reference center for HER2 analysis has not only elevated the quality of public healthcare but also fostered a data-driven approach to diagnostics. Her dedication to reducing healthcare disparities through affordable and accessible diagnostic innovations underscores her suitability for this award. Moreover, her current roles as President of the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology further highlight her influence and commitment to the field.

🎓  Education

Dr. Gaete completed her medical studies at the University of Chile, where she specialized in Anatomopathology. Her passion for advancing medical diagnostics led her to focus on molecular pathology, particularly in breast cancer. She further honed her skills by obtaining advanced training in digital pathology and artificial intelligence (AI) techniques, ensuring she stayed at the forefront of technological innovations in the field. Throughout her career, Dr. Gaete has pursued continuous education, contributing significantly to the implementation of cutting-edge technologies in public health systems. Her work has not only reshaped breast cancer diagnostic processes but has also inspired others in the field to incorporate AI and digital tools to improve healthcare outcomes.

💼  Professional Experience 

Dr. Fancy Gaete Verdejo has dedicated over 26 years of service in the Chilean public healthcare system. As an anatomopathologist, she has specialized in the diagnosis of breast cancer, implementing groundbreaking techniques and driving efficiency in pathology labs. In 2011, she established the national reference center for HER2 in situ hybridization in breast cancer, advancing diagnostic capabilities. Dr. Gaete’s work became more impactful in 2022 when she led the transition from manual FISH HER2 testing to an automated DISH HER2 method, integrating digital pathology with AI algorithms. This transition dramatically improved the turnaround time, reduced costs, and enhanced productivity within the system. Beyond her technical expertise, Dr. Gaete holds leadership roles in major Chilean medical societies, such as the Chilean Society of Pathological Anatomy and the Chilean Society of Mastology, where she contributes to the shaping of national health policies.

🏅  Awards and Recognition

Dr. Gaete’s pioneering contributions have earned her numerous accolades throughout her distinguished career. She has been recognized for her role in advancing breast cancer diagnostics in Chile, particularly through her development of the national reference center for HER2 in situ hybridization. Her innovative work in integrating digital pathology with AI has also been widely acknowledged for improving diagnostic accuracy and system efficiency. Additionally, Dr. Gaete’s leadership in the Chilean Society of Pathological Anatomy (President 2023-2026) and the Chilean Society of Mastology (President 2024-2026) reflects the esteem in which she is held by her peers. These positions have enabled her to influence national healthcare policies and standards in pathology and oncology. Her work has also led to several collaborations with international institutions, further expanding her impact on the global healthcare community.

🌍  Research Skills On Medicine

Dr. Gaete is an expert in anatomical pathology with a deep focus on molecular and digital pathology, particularly in breast cancer. Her research skills include a solid understanding of diagnostic techniques, data analysis, and the integration of innovative technologies such as artificial intelligence (AI) and digital imaging into pathology workflows. She excels in evaluating the economic impact of medical technologies, particularly in healthcare systems. Her research has significantly influenced the adoption of digital pathology and AI in Chile, demonstrating how these tools can optimize diagnostic precision and efficiency. Furthermore, Dr. Gaete is highly skilled in research management, leading both academic and industry collaborations. Her work has contributed to the publication of influential studies on the cost-effectiveness of healthcare technologies, such as her ongoing research on the economic impact of integrative digital pathology in public breast cancer diagnostics.

📖 Publication Top Notes

  • Impact of the Chilean explicit guarantees health system (GES) on breast cancer treatment | Resultados del tratamiento del cáncer de mama, programa nacional de cáncer del adulto
    • Authors: Castillo, C.S.M., Cabrera, M.E.C., Derio P., L., Gaete V., F., Cavada CH., G.
    • Journal: Revista Medica de Chile
    • Year: 2017
    • Volume: 145(12)
    • Pages: 1507–1513
    • Citations: 14
  • Spontaneous quadruplet pregnancy. A challenge for the multidisciplinary team in a health service | Gestación cuádruple espontánea. Un desafío para el equipo multidisciplinario en un servicio de salud
    • Authors: Salgado M., E., Lattus O., J., Barrera C., V., Fritis L., A., Gaete V., F.
    • Journal: Revista Chilena de Obstetricia y Ginecologia
    • Year: 2006
    • Volume: 71(1)
    • Pages: 35–42
    • Citations: 1
  • Jejunal diverticulosis as cause of gastrointestinal hemorrhages. Case report | Diverticulosis yeyunal: Una causa infrecuente de hemorragia digestiva. Caso clínico
    • Authors: Zapata L., R., Rojas S., C., Gaete V., F.
    • Journal: Revista Medica de Chile
    • Year: 2000
    • Volume: 128(10)
    • Pages: 1133–1138
    • Citations: 4

Dr. mahwish iqbal | gynecology | Best Researcher Award

Posted on by sciencefather

Dr. mahwish iqbal | gynecology | Best Researcher Award

Dr. mahwish iqbal, Naseem Jeddah medical center, Saudi Arabia

Dr. Mahwish Iqbal is a passionate gynecologist and obstetrician dedicated to improving women’s health through clinical practice and research. With extensive experience in managing obstetrics and gynecological emergencies, she has provided high-quality care to women across diverse populations. Dr. Iqbal excels at developing educational programs and mentoring future medical professionals, sharing her vast knowledge and surgical skills. Her career is defined by a blend of empathy and a commitment to excellence, marked by achievements like being selected as a consultant gynecologist through the Punjab Public Service Commission. Beyond her clinical work, Dr. Iqbal is actively involved in groundbreaking research on women’s reproductive health, contributing to the medical community’s knowledge base. Fluent in English and Urdu, and proficient in Arabic, she aims to advance in global professional circles and is continuously engaged in academic growth, pursuing various prestigious certifications to expand her expertise.

Professional Profile

orcid

Summary of Suitability for the Research for Best Researcher Award

Mahwish Iqbal demonstrates exceptional expertise and commitment to the field of Obstetrics and Gynecology, making her a strong candidate for the “Research for Best Researcher Award.” Her professional journey is marked by an impressive blend of clinical excellence, academic contributions, and research-driven advancements. She currently serves as a Senior Registrar of Obstetrics and Gynecology at Naseem Jeddah Medical Center, where she manages complex cases, oversees clinical operations, and contributes to the education of medical students. Her role at Batterjee Medical College reflects her dedication to the academic side of medicine, where she has shaped future practitioners through evidence-based teaching and active research project supervision.

🎓 Education

Dr. Mahwish Iqbal earned her MBBS degree from the Services Institute of Medical Sciences in Lahore, Pakistan. She then pursued advanced qualifications in Obstetrics and Gynecology, including the MRCOG from the Royal College of Obstetricians and Gynecologists in the UK and the MRCPI from RCPI in Ireland. Additionally, she has been actively working towards earning the EBCOG-EFOG certification from the European Board and College of Obstetrics and Gynecology since 2024. Dr. Iqbal also holds an FCPS in Obstetrics and Gynecology from the College of Physicians and Surgeons Pakistan, completed in 2021. Her commitment to continuous professional development is evident in her diverse and ongoing academic endeavors. With a deep understanding of women’s reproductive health, Dr. Iqbal is well-versed in modern and traditional medical practices, staying updated with the latest research and evidence-based guidelines to ensure the best possible care for her patients.

💼 Professional Experience

Currently a Senior Registrar at Naseem Jeddah Medical Center, Dr. Mahwish Iqbal leads the obstetrics and gynecology department, handling high-risk cases and managing clinical workflows. From June 2023 to April 2024, she was a dedicated faculty member at Batterjee Medical College, where she taught obstetrics and gynecology, supervised research projects, and administered student assessments. Earlier, she served as a locum registrar and registrar at UDL Polyclinic in Lahore, managing over 30 patients daily, performing complex surgeries, and conducting patient follow-ups. At the Population Welfare Department, she worked as a Woman Medical Officer, delivering maternal and child health guidance and performing contraceptive surgeries. During her residency at Services Hospital in Lahore, Dr. Iqbal gained comprehensive experience in emergency care, patient assessment, and surgical assistance. She consistently demonstrates leadership, a strong ability to mentor medical trainees, and a dedication to improving healthcare outcomes.

🏅Awards and Recognitions

Dr. Mahwish Iqbal has achieved significant accolades throughout her career. She secured first place in the Public Service Commission examination, earning a position as a Woman Medical Officer. Her excellence in the field was further acknowledged when she was selected as a consultant gynecologist by the Punjab Public Service Commission. Dr. Iqbal is also an RCOG Associate, actively contributing to continuous professional development and collaborating with international peers. Her research has gained recognition, focusing on reproductive health issues such as long-acting reversible contraceptives and the use of progesterone in miscarriage management. These achievements underscore her commitment to advancing women’s healthcare. Her professional accomplishments, combined with her impactful research and dedication to patient care, highlight her standing as a respected leader in obstetrics and gynecology. Dr. Iqbal continues to inspire and contribute meaningfully to the medical community.

🌍  Research Skills

Dr. Mahwish Iqbal possesses a strong research acumen in obstetrics and gynecology, particularly focusing on reproductive health issues. She has successfully designed and executed research projects addressing barriers to contraceptive use and optimal treatment for miscarriage prevention. Her research involves data collection, analysis, and presenting findings at professional conferences, showcasing her analytical skills. Dr. Iqbal’s ability to conduct literature reviews and synthesize evidence contributes to impactful studies, like her work on aspirin efficacy in pre-eclampsia prevention. She collaborates effectively with research teams, managing timelines and tasks to ensure successful outcomes. Her expertise extends to writing publications and peer-reviewed articles, with several of her works currently under review. Dr. Iqbal’s research interests include improving obstetric outcomes, optimizing patient management, and exploring innovative solutions for common gynecological issues. She is committed to using her research to drive policy changes and improve healthcare practices for women worldwide.

📖 Publication Top Notes

  • Title: The Thematic Analysis of Barriers to Immediate Post-Partum Long-Acting Reversible Contraception